Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xenon Pharmaceuticals Inc
XENECurrent price
39.83 USD
-1.51 USD (-3.65%)
Last closed
41.75 USD
Company
www.xenon-pharma.com
ISIN
CA98420N1050
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 409 402 368 USD
Yield for 12 month
+35.29 %
1Y
3Y
5Y
10Y
15Y
XENE
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada. Address: 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
56.83 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+9 434 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-167 512 000 USD
Last Year
+9 434 000 USD
Current Quarter
-659 000 USD
Last Quarter
-599 000 USD
Key Figures XENE
1 year
3 years
5 years
10 years
EBITDA
-233 680 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.92 %
PEG Ratio
-0.06
Return On Equity TTM
-26.71 %
Wall Street Target Price
56.83 USD
Revenue TTM
–
Book Value
11.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-96 333 000 USD
Earnings per share
-2.73 USD
Diluted Eps TTM
-2.73 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics XENE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XENE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XENE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
10874.6335
Price Sales TTM
181.4446
Enterprise Value EBITDA
-11.8089
Price Book MRQ
4.0394
Financials XENE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XENE
For 52 weeks
28.1 USD
50.99 USD
50 Day MA
40.97 USD
Shares Short Prior Month
3 301 156
200 Day MA
41.77 USD
Short Ratio
9.67
Shares Short
3 162 517
Short Percent
4.2 %
BeatStart